S8 - Screening Flashcards

1
Q

What is the purpose of screening

A
  • Identifying ‘healthy’ people who may have increased chance of developing a disease or condition
  • Prevent earlier deaths/improve QoL by detecting a condition at a stage where treatment is more effective
  • Reach everyone in target population
  • Reduce the chance of people developing a serious condition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the three types of screening programmes

A

Population
☞ individuals are actively invited for screening
☞ offered to a group of people identified from the whole population
☞ eg by demographics, age, sex

targeted
☞ groups of people identified as being above risk of a specific condition
☞ eg by lifestyle factors, genetic variants or co-morbidity

stratified
☞ offering testing that varies in frequency and modality (varying types of test offered)
☞ this is done according to individual risk
☞ stratification is used in population + targeted screening too
☞ eg people with increased risk of breast cancer can be screened more often depending on their level of risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Give some examples of UK population-based screening programmes

A
  • Diabetic eye
  • Bowel cancer
  • Breast cancer
  • Fetal anomaly
  • Infectious diseases in pregnancy
  • Newborn hearing programme
  • Sickle cell and thalassaemia
  • Newborn blood spot
  • Newborn and infant physical examination
  • Cervical cancer (above 25 y/o)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Criteria for screening

A
  • condition importance of health problem
  • test simple, safe, precise and validated? Acceptable to target population? Αgreed policy on further diagnostic investigation?
  • intervention effective for patients identified through screening? Evidence based policies setting out which individuals should be offered interventions
  • screening programme proven effectiveness in reducing morbidity and mortality? Is programme clinically, socially and ethically acceptable to public + HCPs? Benefit outweigh harms?
  • implementation patient outcomes should be optimised. Quality assurance (management + monitoring), adequate staffing, evidence-cased info available to participants (so they can make informed choice)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pros and cons of screening

A

pros
- Reduce incidence of disease and/or mortality
- Reduce chance of developing condition or complications
- Earlier detection facilitates better treatment outcomes
- Early stage treatment can save money

disadvantages
- False positive
- False negative
- Overdiagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Barriers of screening

A
  • Forgetting
  • Lack of information (and therefore informed choice)
  • Access to screening eg booking
  • Communication eg different languages
  • Physical mobility
  • Financial barriers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why is informed choice in screening important + the principles

A
  • people can respond differently when faced with the same information about the potential benefits and risk
  • decision made based on access to accessible, accurate, evidence-based information covering…
    ☞ the conditions being screened for
    ☞ the testing process
    ☞ risks, limitations and benefits etc
    ☞ potential outcomes and the decisions afterwards
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Screening is a form of…

A

Secondary prevention (Secondary prevention aims to reduce the impact of a disease or injury that has already occurred)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the definition of diagnosis

A

The definitive identification of a suspected disease or defect by application of tests, exams or other procedures to definitely label people as either having a disease or not having a disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

any screening programme is going to make two main errors

A

going to refer well people for further investigation
- false positive
- stress + anxiety
- direct costs
- opportunity costs
**going to fail to refer people who do actually have an early form of the disease
- false negative
- inappropriate reassurance
- possibly delay presentation with symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The features of test validity (details on separate cards)

A
  • sensitivity
  • specificity
  • positive predictive value (PPV)
  • negative predictive value (NPV)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Features of test validity: sensitivity

A
  • the proportion of the people with the disease who test positive
  • aka detection rate
  • the proportion of the people who really have the disease who are identified correctly as having the disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Features of test validity: specificity

A
  • the proportion of people without the disease that test negative
  • the proportion of the people who really do not have the disease who are identified correctly by the test as not having the disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Features of test validity: positive predictive value (PPV)

A
  • ‘if I test positive, do I have the disease’
  • The probability that someone who has tested positive actually has the disease
  • This value is strongly influenced by the prevalence of the disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

features of test validity: negative predictive value (NPP)

A
  • The proportion of people who test negative that actually do not have the disease
  • ‘if the screening test is negative, what are the chances that I really don’t have the disease?’
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Evaluation difficulties (3)

A

lead time bias
- Early diagnosis falsely appears to prolong survival
- Screened patients appear to survive longer, but only because they were diagnosed earlier
- Patients live the same length of time, but longer knowing that they have the disease
length time bias
- Screening programmes are better at picking up slow growing, unthreatening cases than aggressive, fast growing ones
- Diseases that are detectable through screening are more likely to have a favourable prognosis
- Therefore overestimation of survival duration
selection bias
- Worried but healthy individuals are more likely to comply with the screening programme
- Uptake is poorer amongst socioeconomically deprived communities, ethnic minorities and those who are socially excluded

17
Q

Recommendations for improving selection bias

A

build trust and rapport
- Work alongside community
- Ensuring patient participation groups are representative
- Upskilling HCPs on cultural sensitivity and local language
improving access to healthcare
- Alternative times for appointments outside of ‘working hours’
- Mobile clinics
- Utilising tools to aid translation
improve knowledge and awareness
- Making every contact count (MECC) approach
- Engaging homeless population
- Using trusted sources to share info within the community